Malgorzata Beryt
Impact in
- Oncology top 5%
- HER2/EGFR in Cancer Research
- Cancer Treatment and Pharmacology
- Peptidase Inhibition and Analysis
- Cancer Research top 5%
- Breast Cancer Treatment Studies
Papers in
- Oncology 10
- HER2/EGFR in Cancer Research 6
- Cancer Treatment and Pharmacology 3
- Colorectal Cancer Treatments and Studies 2
- Pancreatic and Hepatic Oncology Research 1
-
- Monoclonal and Polyclonal Antibodies Research 5
- Medical Imaging Techniques and Applications 1
- Co-authors
- Mark D. PegramDennis J. SlamonG. KonecnyChristopher J. O’CallaghanRichard J. PietrasGottfried E. KonecnyH. HeppMichael Untch
- Journals
- JNCI Journal of the National Cancer Institute (2 papers)Molecular Cancer Therapeutics (1 paper)Clinical Cancer Research (1 paper)Breast Cancer Research and Treatment (1 paper)Biochemical Pharmacology (1 paper)
- Partner nations
- United StatesGermanyUnited Kingdom
In The Last Decade
Malgorzata Beryt
10 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 83
- Oncology 970
- Cancer Research 345
- Radiology, Nuclear Medicine and Imaging 437
- Genetics 76
- Pulmonary and Respiratory Medicine 220
Countries citing papers authored by Malgorzata Beryt
This map shows the geographic impact of Malgorzata Beryt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Malgorzata Beryt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Malgorzata Beryt more than expected).
Fields of papers citing papers by Malgorzata Beryt
This network shows the impact of papers produced by Malgorzata Beryt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Malgorzata Beryt. The network helps show where Malgorzata Beryt may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Malgorzata Beryt, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2009 | 10 | |
| 2 | 2008 | 28 | |
| 3 | Predicting chemotherapy response to paclitaxel with 18F-Fluoropaclitaxel and PET. | 2006 | 27 |
| 4 | Characterization of HER2 overexpressing breast cell lines selected for long-term culture with trastuzumab | 2005 | 3 |
| 5 | Estimation of paclitaxel biodistribution and uptake in human-derived xenografts in vivo with (18)F-fluoropaclitaxel. | 2005 | 77 |
| 6 | 2004 | 230 | |
| 7 | 2004 | 395 | |
| 8 | 2003 | 454 | |
| 9 | 2001 | 29 | |
| 10 | 2001 | 26 |
About Malgorzata Beryt
Malgorzata Beryt is a scholar working on Oncology, Radiology, Nuclear Medicine and Imaging, Immunology and Allergy, Pharmacology and Molecular Biology, having authored 10 papers that have together received 1.3k indexed citations. Recurring topics across this work include HER2/EGFR in Cancer Research (6 papers), Monoclonal and Polyclonal Antibodies Research (5 papers), Cancer Treatment and Pharmacology (3 papers), Glycosylation and Glycoproteins Research (2 papers), Colorectal Cancer Treatments and Studies (2 papers), Advanced Biosensing Techniques and Applications (1 paper), Pancreatic and Hepatic Oncology Research (1 paper) and Medical Imaging Techniques and Applications (1 paper). The work is most often cited by research in Oncology (970 citations), Cancer Research (345 citations), Radiology, Nuclear Medicine and Imaging (437 citations), Genetics (76 citations) and Pulmonary and Respiratory Medicine (220 citations). Malgorzata Beryt has collaborated with scholars based in United States, Germany and United Kingdom. Frequent co-authors include Mark D. Pegram, Dennis J. Slamon, G. Konecny, Christopher J. O’Callaghan, Richard J. Pietras, Gottfried E. Konecny, H. Hepp, Michael Untch, Ingo Bauerfeind and Hong-Mei Rong. Their work appears in journals such as JNCI Journal of the National Cancer Institute, Molecular Cancer Therapeutics, Clinical Cancer Research, Breast Cancer Research and Treatment and Biochemical Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.